Increase Diagnostic Confidence and Laboratory Productivity With New Novocastra HD Antibodies for IHC
NEWCASTLE, England, August 14, 2012 /PRNewswire/ –
Leica Microsystems announces the introduction of the Novocastra(TM) HD antibody range,
80 clinically important immunohistochemistry antibody clones, spanning 10 anatomical
Novocastra HD was developed to meet the needs of pathologists and histologists, in
terms of menu, diagnostic confidence and workflow. This new ‘Highly Definitive’ range was
created following extensive global market research on customer preferences, combined with
the results of a comprehensive competitive evaluation* of each antibody by NordiQC. The
Novocastra HD menu therefore represents antibodies with independently qualified
performance, each available in a range of new sizes and formats aligned to laboratory
“When it comes to patient diagnosis, we know that excellence in staining quality isn’t
an option – it’s an essential requirement,” says Arnd Kaldowski, President of Leica
Biosystems. “We ensured the optimized performance of each and every product and have
compared performance on BOND with other leading clones in the market on competitive IHC
stainers. The new Novocastra HD range represents our new trusted standard in the selection
of high performing antibodies.”
The Novocastra HD range will be available for sale in the USA and EU from August 2012,
commencing with the breast pathology menu. Leica Microsystems plans to release a further
nine disease specific ranges in 2012 and 2013.
About Leica Microsystems
Leica Microsystems is a world leader in microscopes and scientific instruments.
Founded as a family business in the nineteenth century, the company’s history was marked
by unparalleled innovation on its way to becoming a global enterprise.
Its historically close cooperation with the scientific community is the key to Leica
Microsystems’ tradition of innovation, which draws on users’ ideas and creates solutions
tailored to their requirements. At the global level, Leica Microsystems is organized in
four divisions, all of which are among the leaders in their respective fields: the Life
Science Division, Industry Division, Biosystems Division and Medical Division.
Leica Microsystems’ Biosystems Division, also known as Leica Biosystems, offers
histopathology laboratories the most extensive product range with appropriate products for
each work step in histology and for a high level of productivity in the working processes
of the entire laboratory.
The company is represented in over 100 countries with 12 manufacturing facilities in 7
countries, sales and service organizations in 19 countries and an international network of
dealers. The company is headquartered in Wetzlar, Germany.
For more information contact: Dean Hutchinson Marketing Communications Manager Leica Biosystems Ltd Balliol Business Park West Benton Lane Newcastle upon Tyne NE12 8EW Telephone: +44-191-215-0567 Fax: +44-191-215-1152 Direct Line: +44-191-215-4205 Email: firstname.lastname@example.org
SOURCE Leica Biosystems Ltd